Incremental shuttle walk test as a valuable assessment of exercise performance in patients with pulmonary arterial hypertension

Circulation Journal

Volumn 78, Issue 1, 2014, Pages 215-221

  Irisawa, Hiroshi ^a   Takeuchi, Kazuhiko ^a   Inui, Naoki ^a   Miyakawa, Sachiko ^a   Morishima, Yutaka ^a   Mizushima, Takashi ^a   Watanabe, Hiroshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Exercise; Pulmonary hypertension; Rehabilitation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DISEASE CLASSIFICATION; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMAN; INCIDENCE; MALE; OXYGEN CONSUMPTION; PULMONARY HYPERTENSION; WALKING SPEED; WORKLOAD;

ADULT; AGED; EXERCISE; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WALKING;

EID: 84891122967     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0238     Document Type: Article

References (24)

1. Sun XG, Hansen JE, Oudiz RJ, Wasserman K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104: 429-435.
2. Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 2003; 169: 441-447.
3. Guyatt G, Sullivan M, Thompson P, Fallen E, Pugsley S, Taylor D, et al. The 6-minute walk: A new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132: 919-923.
4. Faggiano P, D'Aloia A, Gualeni A, Lavatelli A, Giordano A. Assessment of oxygen uptake during the six-minute walk test in patients with heart failure: Preliminary experience with a portable device. Am Heart J 1997; 134: 203-206.
5. Cahalin L, Mathier M, Semigran M, Dec G, DiSalvo T. The sixminute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 1996; 110: 325-332.
6. Singh S, Morgan M, Scott S, Waiters D, Hardman A. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019-1024.
7. Singh S, Morgan M, Hardman A, Rowe C, Bardsley P. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994; 7: 2016-2020.
8. Keell S, Chambers J, Francis D, Edwards D, Stables R. Shuttle-walk test to assess chronic heart failure. Lancet 1998; 352: 705.
9. Green DJ, Watts K, Rankin S, Wong P, O'Driscoll JG. A comparison of the shuttle and 6 minute walking tests with measured peak oxygen consumption in patients with heart failure. J Sci Med Sport 2001; 4: 292-300.
10. McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 14S-34S.
11. Ohuchi H, Nakajima T, Kawade M, Matsuda M, Kamiya T. Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol 1996; 17: 7-14.
12. Smith G, Reyes JT, Russell JL, Humpl T. Safety of maximal cardiopulmonary exercise testing in pediatric patients with pulmonary hypertension. Chest 2009; 135: 1209-1214.
13. Weber KT, Janicki JS. Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. Am J Cardiol 1985; 55: 22A-31A.
14. Onorati P, Antonucci R, Valli G, Berton E, De Marco F, Serra P, et al. Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 2003; 89: 331-336.
15. Morales FJ, Martínez A, Méndez M, Agarrado A, Ortega F, Fernández-Guerra J, et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J 1999; 138: 291-298.
16. Morales FJ, Montemayor T, Martinez A. Shuttle versus six-minute walk test in the prediction of outcome in chronic heart failure. Int J Cardiol 2000; 76: 101-105.
17. Fukumoto Y, Shimokawa H. Recent progress in the management of pulmonary hypertension. Circ J 2011; 75: 1801-1810.
18. Wensel R, Opitz CF, Ewert R, Bruch L, Kleber FX. Effects of iloprost inhalation on exercise capacity and ventilatory efficiency in patients with primary pulmonary hypertension. Circulation 2000; 101: 2388-2392.
19. Wax D, Garofano R, Barst RJ. Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension. Chest 1999; 116: 914-920.
20. Fleg JL, Piña IL, Balady GJ, Chaitman BR, Fletcher B, Lavie C, et al. Assessment of functional capacity in clinical and research applications: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association. Circulation 2000; 102: 1591-1597.
21. Meyer K, Westbrook S, Schwaibold M, Hajric R, Peters K, Roskamm H. Short term reproducibility of cardiopulmonary measurements during exercise testing in patients with severe heart failure. Am Heart J 1997; 134: 20-26.
22. Fukumoto Y, Yamada N, Matsubara H, Mizoguchi M, Uchino K, Yao A, et al. Double-blind, placebo-controlled clinical trial with a rhokinase inhibitor in pulmonary arterial hypertension. Circ J 2013; 77: 2619-2625.
23. Yanagisawa R, Kataoka M, Taguchi H, Kawakami T, Tamura Y, Fukuda K, et al. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension. Circ J 2012; 76: 1245-1252.
24. Gallie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005; 353: 2148-2157.